| 131 |
Impact of comorbidities on COVID-19 outcome |
2020 |
| 132 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |
| 133 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |
| 134 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |
| 135 |
Impact of the etiology and Vitamin D receptor TaqI rs731236
gene polymorphism on the severity of acute pancreatitis |
2020 |
| 136 |
Impact of the etiology and Vitamin D receptor TaqI rs731236 gene polymorphism on the severity of acute pancreatitis |
2020 |
| 137 |
Impact of the etiology and Vitamin D receptor TaqI rs731236 gene polymorphism on the severity of acute pancreatitis |
2020 |
| 138 |
In Vitro Antibacterial Potential of Salix babylonica Extract against Bacteria that Affect Oncorhynchus mykiss and Oreochromis spp. |
2020 |
| 139 |
Intricate Relationship Between Adaptive and Innate Immune System in Allergic Contact Dermatitis |
2020 |
| 140 |
Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and
Prevention Strategies |
2020 |
هل لديك سؤال ؟
